Solriamfetol
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 122 publications
Guidelines for the diagnosis and treatment of obstructive sleep apnea in adults (2025)
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: March 12, 2026
Solriamfetol for Excessive Sleepiness in Early-Morning Shift Work Disorder.
Journal: NEJM evidence
Published: January 27, 2026
Pharmacological and non-pharmacological methods of inducing wakefulness activate distinct neural populations in the mouse brain.
Journal: PLoS biology
Published: December 26, 2025
Evaluating solriamfetol interference in urine amphetamine immunoassays: a four-platform comparison.
Journal: Journal of analytical toxicology
Published: December 25, 2025
"Too small to succeed?" Rethinking efficacy claims in a solriamfetol trial for ME/CFS.
Journal: Journal of psychopharmacology (Oxford, England)
Published: December 01, 2025
Real-world effectiveness and tolerability of wake-promoting agents for residual sleepiness in treated obstructive sleep apnea.
Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
Published: October 31, 2025
Drug Interactions With Excessive Daytime Sleepiness Treatments.
Journal: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians
Published: October 07, 2025
Connecting the dots and finding the way forward: Pharmacological, neuromodulatory, and psychotherapeutic interventions for the complex treatment of adult ADHD.
Journal: Pharmacology & therapeutics
Published: October 06, 2025
Impact of solriamfetol treatment on sleep quality in Chinese patients with OSA-EDS: results of a randomized controlled trial.
Journal: Frontiers in medicine
Published: September 24, 2025
Potential treatments for attention-deficit/hyperactivity disorder: a focus on Phase III trials.
Journal: Expert opinion on pharmacotherapy
Published: September 23, 2025
Solriamfetol improves daily fatigue symptoms in adults with myalgic encephalomyelitis/chronic fatigue syndrome after 8 weeks of treatment.
Journal: Journal of psychopharmacology (Oxford, England)
Published: September 17, 2025
Drug-Induced Raynaud's Phenomenon and Underlying Mechanism: A Disproportionality Analysis From the World Health Organization Pharmacovigilance Database.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 24, 2025
Last Updated: 04/28/2026